The Company is a company mainly engaged in the research, development, manufacturing and sale of probiotics. Probiotics are mainly used in products including immune oncology therapeutic supplements, dietary supplements, cosmetics and medicines. These products are mainly applied to obesity, diabetes, acne, atopic dermatitis, and cancer complementary therapies. The Company was founded on September 24, 2015 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on December 26, 2018.
Headquarters
35, Pangyo-Ro 255Beon-Gil, Undang-Gu, Seongnam-Si, Gyeonggi-Do
Seongnam; Gyeonggi;
Contact Details: Purchase the Genome & Company Ltd. report to view the information.
Website: http://genomecom.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service